A dual-response partial least squares regression QSAR model and its application in design of dual activators of PPARα and PPARγ

QSAR and Combinatorial Science

Volumn 27, Issue 11-12, 2008, Pages 1291-1304

  Ajmani, Subhash ^a   Kulkarni, Sudhir A ^a  

^a VLife Sciences Technologies   (India)

Author keywords

Dual activity model and 2D QSAR; PLS; PPAR; QSAR

Indexed keywords

COMPUTATIONAL CHEMISTRY; CYTOLOGY; LEAST SQUARES APPROXIMATIONS; MOLECULAR GRAPHICS; REGRESSION ANALYSIS;

ACTIVITY MODELING; DESCRIPTORS; DUAL ACTIVITY MODEL AND 2D-QUANTITATIVE STRUCTURE - ACTIVITY RELATIONSHIP; DUAL-RESPONSE; PARTIAL LEAST SQUARE REGRESSION; PLS; PPAR; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELING;

STATISTICAL TESTS;

2,4 OXAZOLIDINEDIONE DERIVATIVE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; HYDROGEN BOND; MATHEMATICAL ANALYSIS; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION STUDY;

EID: 58149127485     PISSN: 1611020X     EISSN: 16110218     Source Type: Journal    
DOI: 10.1002/qsar.200810023     Document Type: Article

References (22)

1. T. M. Willson, P. J. Brown, D. D. Sternbach, B. R. Henke, J. Med. Chem. 2000, 43, 527-541.
2. S. Kersten, B. Desvergne, W. Wahli, Nature 2000, 405, 421-424.
3. S. Kliewer, E. Xu, M. Lambert, T. Willson, Recent Prog. Horm. Res. 2001, 56, 239-263.
4. J. Berger, D. Moller, Annu. Rev. Med. 2002, 53, 409-435.
5. H. Bays, L. Mandarino, R. DeFronzo, J. Clin. Endocrinol. Metab. 2004, 89, 463-478.
6. J. Olefsky, J. Clin. Invest. 2000, 106, 467-472.
7. H. Lebovitz, Diabetes Metab. Res. Rev. 2002, 18, S23-S29.
8. S. Robins, D. Collins, J. Wittes, V. Papademetriou, P. Deedwania, E. Schaefer, J. McNamara, M. Kashyap, J. Hershman, L. Wexler, H. Rubins, J. Am. Med. Assoc. 2001, 285, 1585-1591.
9. Diabetes Atherosclerosis Intervention Study Investigators, The Lancet 2001, 357, 905-910.
10. K. Buchan, D. Hassall, Med. Res. Rev. 2000, 20, 350-366.
11. C. Duval, G. Chinetti, F. Trottein, J. Fruchart, B. Staels, Trends Mol. Med. 2002, 8, 422-430.
12. R. C. Desai, W. Han, E. J. Metzger, J. P. Bergman, D. F. Gratale, K. L. MacNaul, J. P. Berger, T. W. Doebber, K. Leung, D. E. Moller, J. V. Heck, S. P. Sahoo, Bioorg. Med. Chem. Lett. 2003, 13, 2795-2798.
13. R. C. Desai, D. F. Gratale, W. Han, H. Koyama, E. J. Metzger, V. K. Lombardo, K. L. MacNaul, T. W. Doebber, J. P. Berger, K. Leung, R. Franklin, D. E. Moller, J. V. Heck, S. P. Sahoo, Bioorg. Med. Chem. Lett. 2003, 13, 3541-3544.
14. VLifeMDS: Molecular Design Suite developed by VLife Sciences Technologies Pvt. Ltd., Pune, India 2007.
15. S. Khanna, M. E. Sobhia, P. V. Bharatam, J. Med. Chem. 2005, 48, 3015-3025.
16. A. Golbraikh, A. Tropsha, A., J. Chem. Inf. Comput. Sci. 2003, 43, 144-154.
17. W. Zheng, A. Tropsha, J. Chem. Inf. Comput. Sci. 2000, 40, 185-194.
18. N. Gilbert, Statistics, W. B. Saunders, Co., Philadelphia, PA 1976.
19. M. Shen, Y. Xiao, A. Golbraikh, V. K. Gombar, A. Tropsha, J. Med. Chem. 2003, 46, 3013-3020.
20. S. Wold, PLS for multivariate linear modelling, in: H. van de Waterbeemd (Ed.), Chemometric Methods in Molecular Design, VCH, Weinheim, Germany 1995, pp. 195-218.
21. S. Wold, A. Ruhe, H. Wold, W. J. Dunn, J. Sci. Stat. Comput. 1984, 5, 735-743.
22. N. Metropolis, A. Rosenbluth, M. Rosenbluth, A. Teller, E. Teller, J. Chem. Phys. 1953, 21, 1087-1092.